Skip to main content
OpenTrials

Clinical trial condition

HER2 Gene Mutation

Explore clinical trials studying HER2 Gene Mutation. Study availability and eligibility vary by location and protocol.

13 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

HER2 Gene Mutation trial results

Recruiting

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

NCT06123338

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +9 more
Locations
  • Massachusetts General Hospital (Data Collection Only) Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Recruiting

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

NCT04620187

Conditions
HER2 Gene Mutation, Head and Neck Neoplasms, Mouth Diseases, +7 more
Locations
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 13 locations
View Trial Details
Recruiting

HEAT Trial (HER2 Antibody Therapy With Lutetium-177)

NCT06824155

Conditions
Advanced Solid Tumors, HER2 Gene Mutation
Locations
  • Nepean Hospital Kingswood, New South Wales, Australia
  • Macquarie University Hospital Macquarie Park, New South Wales, Australia
  • Wollongong Hospital Wollongong, New South Wales, Australia
  • St Vincents Hospital, Melbourne Fitzroy, Victoria, Australia
View Trial Details
Active, not recruiting

Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer

NCT06178445

Conditions
Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +13 more
Locations
  • Universitätsklinikum Augsburg Augsburg, Germany
  • Charité Universitätsmedizin Berlin, Germany
  • Krankenhaus Nordwest (KHNW) Frankfurt, Germany
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Germany
View Trial Details
Active, not recruiting

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

NCT06714617

Conditions
Adnexal Diseases, Breast Cancer Stage III, Breast Diseases, +48 more
Locations
  • SCRI-Denver HealthOne Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • SCRI-Florida Cancer Center Specialists Lake Mary Lake Mary, Florida, United States
  • Hematology Oncology Associates of the Treasure Cost Port Saint Lucie, Florida, United States
View Trial Details
Active, not recruiting

ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer

NCT05650879

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • University of Colorado - Anschutz Medical Campus - PPDS Aurora, Colorado, United States
  • Advent Health Orlando Orlando, Florida, United States
  • BRCR Medical Center Inc Plantation, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 39 locations
View Trial Details

Related conditions